YWYueye Wang

Yueye Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Yueye Wang has a total of 30 co-authors. Here are the top co-authors by number of shared publications:

  • Mingguang He

    School of Optometry, The Hong Kong Polytechnic University, Hong Kong SAR, China

    4 shared publications
  • Xiaotong Han

    State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, Guangdong, China

    4 shared publications
  • Cong Li

    State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangdong Provincial Key Laboratory of Ophthalmology and Visual Science, Guangdong Provincial Clinical Research Center for Ocular Diseases, Guangzhou, China

    2 shared publications
  • Danli Shi

    School of Optometry, The Hong Kong Polytechnic University, Hong Kong, China

    2 shared publications
  • Guankai Peng

    Guangzhou Vision Tech Medical Technology Co, Ltd, Guangzhou, China

    2 shared publications
  • Jian Zhang

    State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, Guangdong, China

    2 shared publications

Latest Publications

  • Cost-effectiveness analysis of human–AI collaboration in disease screening

    by Yueye Wang, Xiaotong Han, Wenyi Hu, Keyao Zhou, Chi Liu, Jian Zhang, Lisa Zhuoting Zhu, Sanil Joseph, Qiuxia Yin, Lixia Luo, et al.


  • Effectiveness of artificial intelligence-based diabetic retinopathy screening in primary care and endocrinology settings in Australia: a pragmatic trial

    by Sanil Joseph, Yueye Wang, Jocelyn J Drinkwater, Catherine Lingxue Jan, Balagiri Sundar, Zhuoting Zhu, Xianwen Shang, Jacqueline Henwood, Katerina Kiburg, Malcolm Clark, et al.

    Purpose To investigate the diagnostic accuracy, feasibility and end-user experiences of an artificial intelligence (AI)-based, automated diabetic retinopathy (DR) screening model in real-world, Australian primary care and endocrinology clinics. Methods In a pragmatic trial conducted across five sites including general practice and endocrinology clinics, from August 2021 to June 2023, patients aged ≥50 years, and those aged ≥18 years with diabetes were screened using an AI-integrated, non-mydriatic fundus camera. The AI instantly analysed the retinal images for referable DR. Patients detected with referable DR or ungradable images were referred to eyecare professionals. The accuracy of the AI grading was assessed against gold standard human grading. A satisfaction survey was administered among the participants and care providers. Results Among 863 participants enrolled (mean (SD) age: 62.6 (13.2) years; 53.0% women), the AI system achieved high accuracy of 93.3% (95% CI: 91.4% to 95.5%) for referable DR detection, with a sensitivity of 83.7% (95% CI: 78.2% to 88.3%), specificity of 96.1% (95% CI: 94.7% to 97.2%) and an area under the receiver operating characteristic curve of 0.899 (95% CI: 0.874 to 0.924). The proportion of ungradable images was lower according to the AI grading (13.4%) compared with human grading (15.6%). Most patients (86%) and care providers (85%) expressed high satisfaction with the AI system. Conclusions The AI-assisted DR screening model was accurate and well received by patients and staff in Australian primary care and endocrinology clinics. This opportunistic screening model holds promise for enhancing early DR detection in non-eyecare settings, potentially preventing vision loss due to DR on a considerable scale.


  • Open Access

    Impact of Gold-Standard Label Errors on Evaluating Performance of Deep Learning Models in Diabetic Retinopathy Screening: Nationwide Real-World Validation Study

    by Yueye Wang, Xiaotong Han, Cong Li, Lixia Luo, Qiuxia Yin, Jian Zhang, Guankai Peng, Danli Shi, Mingguang He

    Background: For medical artificial intelligence (AI) training and validation, human expert labels are considered the gold standard that represents the correct answers or desired outputs for a given data set. These labels serve as a reference or benchmark against which the model’s predictions are compared. Objective: This study aimed to assess the accuracy of a custom deep learning (DL) algorithm on classifying diabetic retinopathy (DR) and further demonstrate how label errors may contribute to this assessment in a nationwide DR-screening program. Methods: Fundus photographs from the Lifeline Express, a nationwide DR-screening program, were analyzed to identify the presence of referable DR using both (1) manual grading by National Health Service England–certificated graders and (2) a DL-based DR-screening algorithm with validated good lab performance. To assess the accuracy of labels, a random sample of images with disagreement between the DL algorithm and the labels was adjudicated by ophthalmologists who were masked to the previous grading results. The error rates of labels in this sample were then used to correct the number of negative and positive cases in the entire data set, serving as postcorrection labels. The DL algorithm’s performance was evaluated against both pre- and postcorrection labels. Results: The analysis included 736,083 images from 237,824 participants. The DL algorithm exhibited a gap between the real-world performance and the lab-reported performance in this nationwide data set, with a sensitivity increase of 12.5% (from 79.6% to 92.5%, P<.001) and a specificity increase of 6.9% (from 91.6% to 98.5%, P<.001). In the random sample, 63.6% (560/880) of negative images and 5.2% (140/2710) of positive images were misclassified in the precorrection human labels. High myopia was the primary reason for misclassifying non-DR images as referable DR images, while laser spots were predominantly responsible for misclassified referable cases. The estimated label error rate for the entire data set was 1.2%. The label correction was estimated to bring about a 12.5% enhancement in the estimated sensitivity of the DL algorithm (P<.001). Conclusions: Label errors based on human image grading, although in a small percentage, can significantly affect the performance evaluation of DL algorithms in real-world DR screening.


  • Towards regulatory generative AI in ophthalmology healthcare: a security and privacy perspective

    by Yueye Wang, Chi Liu, Keyao Zhou, Tianqing Zhu, Xiaotong Han

    As the healthcare community increasingly harnesses the power of generative artificial intelligence (AI), critical issues of security, privacy and regulation take centre stage. In this paper, we explore the security and privacy risks of generative AI from model-level and data-level perspectives. Moreover, we elucidate the potential consequences and case studies within the domain of ophthalmology. Model-level risks include knowledge leakage from the model and model safety under AI-specific attacks, while data-level risks involve unauthorised data collection and data accuracy concerns. Within the healthcare context, these risks can bear severe consequences, encompassing potential breaches of sensitive information, violating privacy rights and threats to patient safety. This paper not only highlights these challenges but also elucidates governance-driven solutions that adhere to AI and healthcare regulations. We advocate for preparedness against potential threats, call for transparency enhancements and underscore the necessity of clinical validation before real-world implementation. The objective of security and privacy improvement in generative AI warrants emphasising the role of ophthalmologists and other healthcare providers, and the timely introduction of comprehensive regulations.


  • Open Access

    Impact of Gold-Standard Label Errors on Evaluating Performance of Deep Learning Models in Diabetic Retinopathy Screening: Nationwide Real-World Validation Study (Preprint)

    by Yueye Wang, Xiaotong Han, Cong Li, Lixia Luo, Qiuxia Yin, Jian Zhang, Guankai Peng, Danli Shi, Mingguang He

    Journal of Medical Internet Research - International Scientific Journal for Medical Research, Information and Communication on the Internet #Preprint #PeerReviewMe: Warning: This is a unreviewed preprint. Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn. Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period. Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author). Background: For medical artificial intelligence (AI) training and validation, human expert labels are considered the gold standard that represents the correct answers or desired outputs for a given data set. These labels serve as a reference or benchmark against which the model’s predictions are compared. Objective: This study aimed to assess the accuracy of a custom deep learning (DL) algorithm on classifying diabetic retinopathy (DR) and further demonstrate how label errors may contribute to this assessment in a nationwide DR-screening program. Methods: Fundus photographs from the Lifeline Express, a nationwide DR-screening program, were analyzed to identify the presence of referable DR using both (1) manual grading by National Health Service England–certificated graders and (2) a DL-based DR-screening algorithm with validated good lab performance. To assess the accuracy of labels, a random sample of images with disagreement between the DL algorithm and the labels was adjudicated by ophthalmologists who were masked to the previous grading results. The error rates of labels in this sample were then used to correct the number of negative and positive cases in the entire data set, serving as postcorrection labels. The DL algorithm’s performance was evaluated against both pre- and postcorrection labels. Results: The analysis included 736,083 images from 237,824 participants. The DL algorithm exhibited a gap between the real-world performance and the lab-reported performance in this nationwide data set, with a sensitivity increase of 12.5% (from 79.6% to 92.5%, P<.001) and a specificity increase of 6.9% (from 91.6% to 98.5%, P<.001). In the random sample, 63.6% (560/880) of negative images and 5.2% (140/2710) of positive images were misclassified in the precorrection human labels. High myopia was the primary reason for misclassifying non-DR images as referable DR images, while laser spots were predominantly responsible for misclassified referable cases. The estimated label error rate for the entire data set was 1.2%. The label correction was estimated to bring about a 12.5% enhancement in the estimated sensitivity of the DL algorithm (P<.001). Conclusions: Label errors based on human image grading, although in a small percentage, can significantly affect the performance evaluation of DL algorithms in real-world DR screening.